Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions (Q37276760)

19 August 2017

1 reference

title

Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions (English)

1 reference

magnetic resonance imaging

19 August 2017

0 references

1 reference

0 references

author name string

Ahmed Ba-Ssalamah

1

1 reference

19 August 2017

Martin Uffmann

2

1 reference

19 August 2017

Sanjai Saini

3

1 reference

19 August 2017

Nina Bastati

4

1 reference

19 August 2017

Christian Herold

5

1 reference

19 August 2017

Wolfgang Schima

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

23 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

19

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

342-357

1 reference

The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Contrast agents for MR imaging of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Cystic focal liver lesions in the adult: differential CT and MR imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Maintenance immunosuppression after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Early hepatocellular carcinoma: MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Characterization of focal hepatic lesions with SPIO-enhanced MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-008-1172-X

Central scars in primary liver tumors: MR features, specificity, and pathologic correlation

21 January 2018

1 reference

12 December 2020

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis

1 reference

12 December 2020

MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation

1 reference

12 December 2020

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

1 reference

12 December 2020

Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA

1 reference

12 December 2020

Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression

1 reference

12 December 2020

Management of metastatic cancer to the liver.

1 reference

12 December 2020

Dynamic MR imaging of liver metastases with Gd-EOB-DTPA.

1 reference

12 December 2020

Spectrum of MRI appearances of untreated metastases of the liver

1 reference

12 December 2020

Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications

1 reference

12 December 2020

Liver pathology associated with the use of anabolic-androgenic steroids

1 reference

12 December 2020

Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system

1 reference

12 December 2020

Atypical hepatic hemangiomas with intense arterial enhancement and early fading

1 reference

12 December 2020

Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions

1 reference

12 December 2020

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

1 reference

12 December 2020

Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.

1 reference

12 December 2020

MnDPDP enhanced magnetic resonance imaging of focal liver lesions

1 reference

12 December 2020

The continuing challenge of hepatic cancer in Asia

1 reference

12 December 2020

Magnetic resonance imaging of hepatocellular carcinoma

1 reference

12 December 2020

Hepatic adenoma: MR characteristics and correlation with pathologic findings

1 reference

12 December 2020

Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report

1 reference

12 December 2020

1 reference

12 December 2020

Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features

1 reference

12 December 2020

Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms

1 reference

12 December 2020

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

1 reference

12 December 2020

Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications

1 reference

12 December 2020

Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images

1 reference

12 December 2020

Specificity of SPIO particles for characterization of liver hemangiomas using MRI

1 reference

12 December 2020

Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.

1 reference

12 December 2020

MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses

1 reference

12 December 2020

Magnetic resonance imaging of liver malignancies

1 reference

12 December 2020

Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA.

1 reference

12 December 2020

Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.

1 reference

12 December 2020

T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging

1 reference

12 December 2020

The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology

1 reference

12 December 2020

Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences

1 reference

12 December 2020

Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation

1 reference

12 December 2020

Giant hemangioma of the liver: MR imaging characteristics in 24 patients

1 reference

12 December 2020

Contrast agents for hepatic MRI.

1 reference

12 December 2020

Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.

1 reference

12 December 2020

MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool

1 reference

12 December 2020

Uptake of mangafodipir trisodium in liver metastases from endocrine tumors

1 reference

12 December 2020

Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

1 reference

12 December 2020

Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media

1 reference

12 December 2020

Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging

1 reference

12 December 2020

Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

1 reference

12 December 2020

Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient

1 reference

12 December 2020

Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP

1 reference

12 December 2020

Hepatic MR Imaging with Ferumoxides: Multicenter Study of Safety and Effectiveness of Direct Injection Protocol

1 reference

12 December 2020

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

1 reference

12 December 2020

Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome

1 reference

12 December 2020

Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular adenoma: MR imaging features with pathologic correlation

1 reference

12 December 2020

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

1 reference

12 December 2020

Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.

1 reference

12 December 2020

MR imaging of cirrhosis and its complications

1 reference

12 December 2020

MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents

1 reference

12 December 2020

10.1007/S00330-008-1172-X

Identifiers

DOI

1 reference

19 August 2017

1 reference